All articles by Vemula Pravalika

Vemula Pravalika

Pioneering Cutting-Edge Technologies: High-End Medical Imaging Developer VITAL HealthCare Debuts at CMEF

On Apr. 11, 2024, VITAL HealthCare, one of the 5 core business divisions of the VITAL Group, marked a stunning debut at the 89th China International Medical Equipment Fair (CMEF) in Shanghai. Drawing on the Group’s core competence in R&D and its wealth of top-quality raw materials, devices, modules, and system R&D resources, VITAL HealthCare has captured the spotlight with its forward-looking product development plan on this inaugural showcase.

Insightec Announces Exablate Prime Availability In Europe -The next generation Of MR-guided focused ultrasound

Insightec reaffirms its position at the forefront of the medical technology industry with improved functionality, safety features, and efficiency to its flagship product, setting new benchmarks in the field with unparalleled achievements.

89th CMEF in Shanghai Elevates Global Medical Device Trade to The Next Level

The 89th edition of the China International Medical Equipment Fair (CMEF) witnessed an impressive turnout of over 200,000 attendees from more than 150 countries. Prominent companies in the industry seized the opportunity to showcase their cutting-edge products and comprehensive solutions, covering every aspect of the industry chain. The exhibition served as a dynamic platform for collaboration, innovation, and exploration, significantly boosting global medical device trade.

CSafe Elevates Cell and Gene Therapy Transport with Reusable Cryogenic Solution

CSafe, an active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, proudly announces the launch of a new line of cryogenic multi-use dewars for the cell and gene therapy market. The progressive technology, which is the first in CSafe’s CGT Cryo Series, maintains temperatures colder than -150°C.

WHS Ranks Topical Oxygen Level 1 Evidence

Exciting news in the realm of wound care! The Wound Healing Society has recently increased topical oxygen therapy to ‘Level 1’ evidence in its updated DFU treatment guidelines, signifying a significant leap in the field.

TATAA Biocenter Achieves GLP Accreditation for qPCR and dPCR

TATAA Biocenter announced that it has been awarded Good Laboratory Practice (GLP) accreditation. The accreditation represents a crucial step in the company’s strategic progression into a market leading molecular analysis contract research organization (CRO) expediting biopharmaceutical innovations in advanced therapies and precision medicine.

Cepheid Announces World Health Organization Prequalification of Xpert HIV-1 Qualitative Test

Point of Care HIV diagnostic testing for infants and early detection of HIV infections

Greenspace and Welligent partner to improve behavioural healthcare

Greenspace’s measurement-based care platform will integrate with Welligent’s cloud-based EHR software for behavioural health.

QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a series of new products to further enhance cancer research as well as to enable urine collection and stabilization as a new approach for liquid biopsy.